Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma

Published Date: 10 Jan 2025

Phase III data show promising efficacy with manageable toxicity and feasible delivery

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

SBRT May Beat Brachytherapy in Prostate Cancer

2.

New Gene Therapy Nears EU Nod for Bladder Cancer

3.

EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer

4.

Simpler Screening Criteria Could Catch More Lung Cancers

5.

Early Identification of Ovarian Cancer; Allergy Medicine for NSCLC? Unfavorable Development for Anti-TIGIT Medication?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot